Myoblasts generated by lentiviral mediated MyoD transduction of myotonic dystrophy type 1 (DM1) fibroblasts can be used for assays of therapeutic molecules
<p>Abstract</p> <p>Background</p> <p>Myotonic dystrophy type 1 (DM1) is the most common muscle dystrophy in adults. The disease is caused by a triplet expansion in the 3'end of the myotonic dystrophy protein kinase (<it>DMPK) </it>gene. In order to deve...
Main Authors: | Larsen Jan, Pettersson Olof J, Jakobsen Maria, Thomsen Rune, Pedersen Christina B, Hertz Jens M, Gregersen Niels, Corydon Thomas J, Jensen Thomas G |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | BMC Research Notes |
Online Access: | http://www.biomedcentral.com/1756-0500/4/490 |
Similar Items
-
Loss of MyoD Promotes Fate Transdifferentiation of Myoblasts Into Brown Adipocytes
by: Chao Wang, et al.
Published: (2017-02-01) -
LSD1 Controls Timely MyoD Expression via MyoD Core Enhancer Transcription
by: Isabella Scionti, et al.
Published: (2017-02-01) -
Epicatechin elicits MyoD-dependent myoblast differentiation and myogenic conversion of fibroblasts.
by: Sang-Jin Lee, et al.
Published: (2017-01-01) -
MyoD induces ARTD1 and nucleoplasmic poly-ADP-ribosylation during fibroblast to myoblast transdifferentiation
by: Lavinia Bisceglie, et al.
Published: (2021-05-01) -
Myoblast Myogenic Differentiation but Not Fusion Process Is Inhibited via MyoD Tetraplex Interaction
by: Stefano Testa, et al.
Published: (2018-01-01)